ArticlePLOS digital health2026
Functional connectivity-based classification and subtyping of major depression for precision mental health: An ensemble graph neural network approach.
Article in PLOS digital health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Major depressive disorder (MDD) remains clinically diagnosed based on subjective symptoms rather than objective neurobiological markers, which limits diagnostic accuracy and the ability to tailor treatment. We present an ensemble hybrid framework that integrates graph neural networks (GNN) with unsupervised clustering to classify and subtype MDD using resting-state functional connectivity (rs-fMRI) profiles. A GNN was trained to distinguish MDD from healthy controls using functional connectivity derived brain graphs, and the resulting subject level embeddings were clustered to uncover subtype structure. We evaluated the approach on two public multisite cohorts, REST-meta-MDD (China; N = 1,604; 17 sites) and SRPBS (Japan; N = 446; 4 sites), using leave-one-site-out cross-validation and cross-national transfer. The classifier achieved 0.73 leave-one-site-out accuracy on REST-meta-MDD and retained 0.78 sensitivity when transferred from the Chinese to the Japanese cohort, outperforming BrainIB and CI GNN under the same protocol. To mitigate site related confounds, we applied a standardized preprocessing pipeline and ComBat harmonization. Clustering consistently identified three MDD subtypes with distinct connectivity signatures involving the default mode network and cerebellum, the insula-cingulum temporal circuit, and frontostriatal circuitry. These findings provide a reproducible and biologically interpretable stratification of MDD. Prospective studies will be needed to link these subtypes to treatment response and other clinically meaningful outcomes.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.